The field of life sciences is witnessing a remarkable era of innovation, characterised by breakthroughs across scientific domains that are revolutionising drug discovery and development.
Healthcare intelligence provider Wilmington Healthcare has won its first client for an innovative new service that helps pharma keep abreast of change within local NHS organisations and better unde
The US FDA announced today that it has cleared two novel gene therapies for sickle cell disease: Vertex Pharmaceuticals' Casgevy and bluebird bio's Lyfgenia.
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio